Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -12,50k | 1,53M | Automatic Disposition | 118,81 - 124,74 | 175,00k | -6,67% |
| 2026-07-06 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -26,25k | 3,13M | Derivative Exercise and Sale | 2,80 - 124,61 | 175,00k | - |
| 2026-07-01 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | -801,00 | 100,06k | Automatic Disposition | 124,91 | 21,10k | -3,66% |
| 2026-06-29 | Dr. John ten BoschSVP of Laboratory Operations | -1,42k | 169,92k | Automatic Disposition | 120,00 | 33,55k | -4,05% |
| 2026-06-24 | Ms. Shan Riku SakakibaraChief Product Officer | -4,00k | 440,00k | Automatic Disposition | 110,00 | 208,00k | -1,89% |
| 2026-06-24 | Ms. Shan Riku SakakibaraChief Product Officer | -4,00k | 405,40k | Derivative Exercise and Sale | 8,65 - 110,00 | 208,00k | - |
| 2026-06-15 | Dr. John ten BoschSVP of Laboratory Operations | -2,83k | 287,36k | Automatic Disposition | 101,47 | 34,97k | -7,49% |
| 2026-06-15 | Dr. David TsaoCo-Founder, President, CTO & Director | -20,00k | 1,99M | Derivative Exercise and Sale | 2,80 - 104,47 | 1.000,00 | - |
| 2026-06-09 | NeoTribe VenturesUnternehmen | -435,95k | 0,00 | Other Disposition | - | 3,49M | -11,11% |
| 2026-06-08 | Ms. Shan Riku SakakibaraChief Product Officer | -8,00k | 785,80k | Automatic Disposition | 96,45 - 100,00 | 212,00k | -3,64% |
| 2026-06-08 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | -14,00k | 1,40M | Automatic Disposition | 99,09 - 102,34 | 21,90k | -39,00% |
| 2026-06-08 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -36,25k | 2,49M | Derivative Exercise and Sale | 2,80 - 100,87 | 187,50k | - |
| 2026-06-08 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -12,50k | 1,23M | Automatic Disposition | 96,45 - 100,00 | 187,50k | -6,25% |
| 2026-06-08 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -10,00k | 0,00 | Other Disposition | - | 2,22M | -0,45% |
| 2026-05-11 | NeoTribe VenturesUnternehmen | -441,37k | 0,00 | Other Disposition | - | 3,92M | -10,11% |
| 2025-11-07 | Hummingbird Ventures Management NVUnternehmen | -7,71M | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-07 | Hummingbird Ventures Management NVUnternehmen | -180,00k | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Mr. Thomas P. LynchCCO, General Counsel & Secretary | -600,00 | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Mr. Thomas P. LynchCCO, General Counsel & Secretary | -144,40k | 0,00 | Other Derivative Disposition | 8,65 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Mr. Thomas P. LynchCCO, General Counsel & Secretary | 100,00 | 6,00k | Kauf | 60,00 | 700,00 | 16,67% |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -262,43k | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -2,17M | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -1,64M | 0,00 | Other Derivative Disposition | 2,80 - 20,04 | 0,00 | -100,00% |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -2,23M | 0,00 | Other Disposition | - | 200,00k | -91,76% |
| 2025-11-07 | Dr. Oguzhan AtayCo-Founder, Chairman & CEO | -2,23M | 0,00 | Other Disposition | - | 2,23M | -50,00% |
| 2025-11-07 | Dr. David TsaoCo-Founder, President, CTO & Director | -2,33M | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Dr. David TsaoCo-Founder, President, CTO & Director | -1,14M | 0,00 | Other Derivative Disposition | 2,80 - 20,04 | 0,00 | -100,00% |
| 2025-11-07 | Dr. David TsaoCo-Founder, President, CTO & Director | 1.000,00 | 60,00k | Kauf | 60,00 | 1.000,00 | - |
| 2025-11-07 | Dr. David TsaoCo-Founder, President, CTO & Director | -2,33M | 0,00 | Other Disposition | - | 1.000,00 | -99,96% |
| 2025-11-07 | Ms. Shan Riku SakakibaraChief Product Officer | -220,00k | 0,00 | Other Disposition | - | 220,00k | -50,00% |
| 2025-11-07 | Ms. Shan Riku SakakibaraChief Product Officer | -155,00k | 0,00 | Other Derivative Disposition | 2,80 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Dr. John ten BoschSVP of Laboratory Operations | 800,00 | 48,00k | Kauf | 60,00 | 37,80k | 2,16% |
| 2025-11-07 | Dr. John ten BoschSVP of Laboratory Operations | -37,00k | 0,00 | Other Disposition | - | 37,80k | -49,47% |
| 2025-11-07 | Dr. John ten BoschSVP of Laboratory Operations | -131,00k | 0,00 | Other Derivative Disposition | 0,56 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Mr. Ross TaylorCFO | -250,00k | 0,00 | Other Derivative Disposition | 11,55 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Mr. John D. ListerChief Administrative Officer | -133,30k | 0,00 | Other Derivative Disposition | 23,15 | 0,00 | -100,00% |
| 2025-11-07 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | 6,90k | 414,00k | Kauf | 60,00 | 35,90k | 23,79% |
| 2025-11-07 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | -29,00k | 0,00 | Other Disposition | - | 35,90k | -44,68% |
| 2025-11-07 | Ms. Nancy JohnsonSVP of Sales & Commercial Operations | -275,00k | 0,00 | Other Derivative Disposition | 0,45 - 30,78 | 0,00 | -100,00% |
| 2025-11-07 | Mr. Akshay RaiIndependent Director | 2,50k | 150,00k | Kauf | 60,00 | 5,18k | 93,42% |
| 2025-11-07 | Wipro Enterprises Private LimitedUnternehmen | -1,78M | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-07 | Mr. Akshay RaiIndependent Director | 2,68k | 0,00 | Derivative Exercise and Retained Stock | - | - | - |
| 2025-11-07 | Mr. Akshay RaiIndependent Director | -11,01k | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Mr. Krishna Swaroop KolluriIndependent Director | -8,33k | 0,00 | Other Disposition | - | - | - |
| 2025-11-07 | Adams Street Partners, LLCUnternehmen | 41,67k | 2,50M | Kauf | 60,00 | 1,71M | 2,50% |
| 2025-11-07 | Adams Street Partners, LLCUnternehmen | -1,67M | 0,00 | Derivative Exercise and Sale | - | 1,71M | - |
| 2025-11-07 | Mr. Thomas S. BremnerIndependent Director | -8,33k | 0,00 | Other Disposition | - | 0,00 | -100,00% |
| 2025-11-07 | FundRock Management Company S.A.Unternehmen | -277,51k | 0,00 | Derivative Exercise and Sale | - | 277,51k | - |
| 2025-11-07 | Hummingbird Ventures Management NVUnternehmen | 7,71M | 0,00 | Derivative Exercise and Retained Stock | - | 7,89M | 4.281,79% |
| 2025-11-07 | Hummingbird Ventures Management NVUnternehmen | -7,89M | 0,00 | Other Disposition | - | 7,89M | -50,00% |
| 2025-11-07 | Mr. Firat IleriLead Independent Director | 28,98k | 0,00 | Derivative Exercise and Retained Stock | - | 28,98k | - |
| 2025-11-07 | Mr. Firat IleriLead Independent Director | -37,31k | 0,00 | Other Disposition | - | 28,98k | -56,28% |
| 2025-11-07 | NeoTribe VenturesUnternehmen | -4,24M | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-07 | NeoTribe VenturesUnternehmen | -120,00k | 0,00 | Other Disposition | - | - | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
